Literature DB >> 7533431

Phase II FK 506 multicenter concentration control study: one-year follow-up.

D A Laskow1, F Vincenti, J Neylan, R Mendez, A Matas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7533431

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  7 in total

Review 1.  Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data.

Authors:  Angela C Webster; Rebecca C Woodroffe; Rod S Taylor; Jeremy R Chapman; Jonathan C Craig
Journal:  BMJ       Date:  2005-09-12

2.  Comparison of whole-blood tacrolimus concentrations measured by different immunoassay systems.

Authors:  Tetsuya Kaneko; Takashi Fujioka; Yosuke Suzuki; Toshiaki Nagano; Yuhki Sato; Syunji Asakura; Hiroki Itoh
Journal:  J Clin Lab Anal       Date:  2018-07-05       Impact factor: 2.352

3.  Tacrolimus in pediatric renal transplantation.

Authors:  R Shapiro; V P Scantlebury; M L Jordan; C Vivas; H A Gritsch; D Ellis; N Gilboa; S Lombardozzi-Lane; W Irish; J J Fung; T R Hakala; R L Simmons; T E Starzl
Journal:  Transplantation       Date:  1996-12-27       Impact factor: 4.939

Review 4.  A risk-benefit assessment of tacrolimus in transplantation.

Authors:  M Winkler; U Christians
Journal:  Drug Saf       Date:  1995-05       Impact factor: 5.606

5.  Two doses of humanized anti-CD25 antibody in renal transplantation: a preliminary comparative study.

Authors:  Jing Li; Xinyan Li; Min Tan; Birong Lin; Sheng Hou; Weizhu Qian; Bohua Li; Dapeng Zhang; Bo Zhou; Hao Wang; Tongyu Zhu; Yajun Guo
Journal:  MAbs       Date:  2009 Jan-Feb       Impact factor: 5.857

Review 6.  The superiority of tacrolimus in renal transplant recipients -- the Pittsburgh experience.

Authors:  R Shapiro; M L Jordan; V P Scantlebury; C Vivas; H A Gritsch; R J Corry; F Egidi; J McCauley; D Ellis; N Gilboa
Journal:  Clin Transpl       Date:  1995

7.  Cellular immune suppression in paraneoplastic neurologic syndromes targeting intracellular antigens.

Authors:  Dana Orange; Mayu Frank; Suyan Tian; Athanasios Dousmanis; Ronen Marmur; Noreen Buckley; Salina Parveen; Jerome J Graber; Nathalie Blachère; Robert B Darnell
Journal:  Arch Neurol       Date:  2012-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.